William Edward Costanzo, MD | |
3140 Princeton Pike, 2nd Floor, Lawrenceville, NJ 08648-2306 | |
(609) 895-1919 | |
(609) 895-1200 |
Full Name | William Edward Costanzo |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 37 Years |
Location | 3140 Princeton Pike, Lawrenceville, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376531517 | NPI | - | NPPES |
7485409 | Medicaid | NJ |
Facility Name | Location | Facility Type |
---|---|---|
Capital Health Medical Center - Hopewell | Pennington, NJ | Hospital |
Capital Health Regional Medical Center | Trenton, NJ | Hospital |
Robert Wood Johnson University Hospital At Hamilton | Hamilton, NJ | Hospital |
University Medical Center Of Princeton At Plainsboro | Plainsboro, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Capital Health Medical Group | 7618264532 | 364 |
Capital Health Medical Group | 7618264532 | 364 |
News Archive
Experts studying the impact of bereavement on people's health have found that the chances of a heart or stroke attack doubles after a partner's death.
The scientific consensus is that safe and highly effective vaccines are required to end the ongoing pandemic of coronavirus disease 2019 COVID-19, caused by SARS-CoV-2. A new study describes a new vaccine that presents two viral antigens to the human immune system, in order to elicit a more efficacious response.
Results from the first and only interim analysis of an important trial assessing the potential of Herceptin (trastuzumab) to improve disease-free survival (DFS) in HER-2 positive breast cancer patients after adjuvant chemotherapy, have shown that Herceptin affords a significant survival advantage.
An innovative model for determining a person's risk of developing type 2 diabetes (T2D) overcomes many of the challenges associated with estimating the onset of a chronic condition based on the usual sequence of comorbid conditions that lead up to a diagnosis of T2D.
› Verified 2 days ago
Entity Name | Mercer Physician Services Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124369822 PECOS PAC ID: 2264670330 Enrollment ID: O20130531000026 |
News Archive
Experts studying the impact of bereavement on people's health have found that the chances of a heart or stroke attack doubles after a partner's death.
The scientific consensus is that safe and highly effective vaccines are required to end the ongoing pandemic of coronavirus disease 2019 COVID-19, caused by SARS-CoV-2. A new study describes a new vaccine that presents two viral antigens to the human immune system, in order to elicit a more efficacious response.
Results from the first and only interim analysis of an important trial assessing the potential of Herceptin (trastuzumab) to improve disease-free survival (DFS) in HER-2 positive breast cancer patients after adjuvant chemotherapy, have shown that Herceptin affords a significant survival advantage.
An innovative model for determining a person's risk of developing type 2 diabetes (T2D) overcomes many of the challenges associated with estimating the onset of a chronic condition based on the usual sequence of comorbid conditions that lead up to a diagnosis of T2D.
› Verified 2 days ago
Entity Name | Capital Health Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1437516887 PECOS PAC ID: 7618264532 Enrollment ID: O20160921000449 |
News Archive
Experts studying the impact of bereavement on people's health have found that the chances of a heart or stroke attack doubles after a partner's death.
The scientific consensus is that safe and highly effective vaccines are required to end the ongoing pandemic of coronavirus disease 2019 COVID-19, caused by SARS-CoV-2. A new study describes a new vaccine that presents two viral antigens to the human immune system, in order to elicit a more efficacious response.
Results from the first and only interim analysis of an important trial assessing the potential of Herceptin (trastuzumab) to improve disease-free survival (DFS) in HER-2 positive breast cancer patients after adjuvant chemotherapy, have shown that Herceptin affords a significant survival advantage.
An innovative model for determining a person's risk of developing type 2 diabetes (T2D) overcomes many of the challenges associated with estimating the onset of a chronic condition based on the usual sequence of comorbid conditions that lead up to a diagnosis of T2D.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
William Edward Costanzo, MD 104 Pheasant Run, Suite 128, Newtown, PA 18940-3439 Ph: (215) 860-3344 | William Edward Costanzo, MD 3140 Princeton Pike, 2nd Floor, Lawrenceville, NJ 08648-2306 Ph: (609) 895-1919 |
News Archive
Experts studying the impact of bereavement on people's health have found that the chances of a heart or stroke attack doubles after a partner's death.
The scientific consensus is that safe and highly effective vaccines are required to end the ongoing pandemic of coronavirus disease 2019 COVID-19, caused by SARS-CoV-2. A new study describes a new vaccine that presents two viral antigens to the human immune system, in order to elicit a more efficacious response.
Results from the first and only interim analysis of an important trial assessing the potential of Herceptin (trastuzumab) to improve disease-free survival (DFS) in HER-2 positive breast cancer patients after adjuvant chemotherapy, have shown that Herceptin affords a significant survival advantage.
An innovative model for determining a person's risk of developing type 2 diabetes (T2D) overcomes many of the challenges associated with estimating the onset of a chronic condition based on the usual sequence of comorbid conditions that lead up to a diagnosis of T2D.
› Verified 2 days ago
Michael Roy Dash, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 123 Franklin Corner Rd, Suite 216, Lawrenceville, NJ 08648 Phone: 609-895-6800 Fax: 609-895-6988 | |
Dr. Neel Jitendra Gandhi, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2997 Princeton Pike, #201, Lawrenceville, NJ 08648 Phone: 609-771-0700 Fax: 609-771-8466 | |
Dr. Humaira Naseem Adenwalla, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3100 Princeton Pike Ste D, Lawrenceville, NJ 08648 Phone: 609-910-5556 | |
Dr. Sarah Anne Werbel, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3100 Princeton Pike, Bldg 4, Suite I, Lawrenceville, NJ 08648 Phone: 609-896-0303 Fax: 609-896-0308 | |
Dr. Robert Silverbrook, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3131 Princeton Pike, Suite204, Lawrenceville, NJ 08648 Phone: 609-306-8924 Fax: 215-364-3139 | |
Mrs. Daphne Duvalsaint Dadzie, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 168 Franklin Corner Rd, Building 1, Suite 2a, Lawrenceville, NJ 08648 Phone: 609-896-0075 Fax: 609-896-0079 | |
Dr. Jason Hollander, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 168 Franklin Corner Rd Bldg 1, Lawrenceville, NJ 08648 Phone: 609-924-4433 Fax: 609-924-4423 |